Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
This study has been completed.
Study NCT00402506   Information provided by Medicure

First Received on November 20, 2006.   Last Updated on November 15, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myocardial Ischemia
Reperfusion Injury
Additional conditions recognized in this trial
Coronary Artery Disease
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Pathologic Processes
Postoperative Complications
Vascular Diseases
Interventions listed in this trial
(MC-1) Pyridoxal 5'-phosphate
Additional drug interventions recognized in this trial
Pyridoxal
Pyridoxal Phosphate
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Medicure


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services